Forte Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
FBRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
3060 Pegasus Park Drive, Building 6, Dallas, TX

Insiders trading volume in the past year

Forte Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul A. Wagner CEO, Secretary and Chair of the Board, Director $792K Apr 1, 2025
Antony A. Riley Chief Financial Officer $251K +$125K +98.8% Apr 1, 2025
Hubert C. Chen President and Chief Scientific Officer $151K Jan 1, 2024
Barbara K. Finck Director Mar 19, 2025
Stephen K. Doberstein Director Mar 20, 2025
Scott C. Brun Director Mar 20, 2025
Shivpreet Singh Kapoor Director Mar 20, 2025
Donald Williams Director Aug 20, 2024
Steven Kornfeld Director Mar 20, 2025
Lawrence Eichenfield Director Aug 20, 2024
David W. Gryska Director Mar 20, 2025
Richard G. Vincent Director Mar 20, 2025
Patricia S. Walker Director Jun 1, 2022

Recent Insider Transactions by Companies or Individuals for Forte Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.